Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1SL2W
|
|||
| Drug Name |
PRT811
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Glioma [ICD-11: 2A00.0] | Phase 1 | [1] | |
| Company |
Prelude Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Protein arginine methyltransferase 5 (PRMT5) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04089449) A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Prelude Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.